Skip to main content
Premium Trial:

Request an Annual Quote

Two New RNAi-Related Patent Applications Published By US Patent Office, March 19, 2004


Title: Eukaryotic Cell Division Genes and Their Use in Diagnosis and Treatment of Proliferative Diseases. Number: 20040048277. Filed: Sept. 8, 2003 (PCT Filed: Nov. 9, 2001). Lead Inventor: Christophe Echeverri, Cenix Bioscience.

According to the patent application’s abstract, the invention “relates to the significant functional role of several C. elegans genes and of their corresponding gene products in cell division and proliferation processes that could be identified by means of RNA-mediated interference, and to the identification and isolation of functional orthologs of said genes including all biologically-active derivatives thereof.”

The abstract adds that the invention “further relates to the use of said gene products (including said orthologs) in the development or isolation of anti-proliferative agents, particularly their use in appropriate screening assays, and their use for diagnosis and treatment of proliferative diseases.”

Title: Compositions and Methods for Treatment of Hepatitis C Virus-Associated Diseases. Number: 20040049021. Filed: June 4, 2003. Lead Inventor: Kevin Anderson, Isis Pharmaceuticals.

The patent application, its abstract states, covers “antisense oligonucleotides … which are complementary to and hybridizable with at least a portion of HCV RNA and which are capable of inhibiting the function of the HCV RNA.”

The patent application specifically claims a double-stranded “RNA compound between eight and 80 nucleobases in length targeted to HCV genomics or messenger RNA.”

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.